Steven Burke

Chief Tech/Sci/R&D Officer at AKEBIA THERAPEUTICS, INC.

Net worth: 502 783 $ as of 2026-08-30

65 year

Health Technology

Consumer Services

Profile

Steven K.
Burke is currently Director at LeukoSight, Inc. and AbFero Pharmaceuticals, Inc. Since 2019, Dr. Burke has been Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. Formerly, Dr. Burke was Medical Director & VP-Clinical Research at GelTex Pharmaceuticals, Inc. from 1994 to 2001, Associate Director-Clinical Research at Glaxo, Inc., Senior VP-Medical and Regulatory Affairs at Genzyme Corp.
in 2011, Chief Medical Officer & Senior Vice President at Proteon Therapeutics, Inc. from 2006 to 2019, and Chief Medical Officer at Protara Therapeutics, Inc. Education includes a doctorate from Weill Cornell Medical College and undergraduate studies at Harvard College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AKEBIA THERAPEUTICS, INC. 0.2%	2026-03-30	547,098 ( 0.2% )	502 783 $	2026-08-30

Steven Burke active positions

Companies	Position	Start
AKEBIA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2019-06-16
LeukoSight, Inc. LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases	Director/Board Member	-
AbFero Pharmaceuticals, Inc. AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload	Director/Board Member	-

All active positions of Steven Burke

Former positions of Steven Burke

Companies	Position	End
PROTARA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2018-12-31
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals	Chief Tech/Sci/R&D Officer	2000-12-31
PROTARA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-
Glaxo, Inc.	Corporate Officer/Principal	-
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Chief Tech/Sci/R&D Officer	-

See the detail of Steven Burke's experience

Training of Steven Burke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven Burke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Proteon Therapeutics, Inc. Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease	Health Technology
Akebia Therapeutics, Inc. Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases	Health Technology
Glaxo, Inc.
LeukoSight, Inc. LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases	Health Technology
Weill Cornell Medical College Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AbFero Pharmaceuticals, Inc. AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload	Health Technology
Protara Therapeutics, Inc. Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology